Johnson & Johnson’s 1-shot COVID-19 vaccine shows promise in early-stage trials

Johnson & Johnson’s 1-shot COVID-19 vaccine shows promise in early-stage trialsПодробнее

Johnson & Johnson's single-dose COVID-19 vaccine shows promising results in early trialsПодробнее

First One-Shot Covid Vaccine from Johnson & Johnson Proves Effective: StudyПодробнее

Johnson and Johnson says 1-shot vaccine shows promising results in early trial | WNTПодробнее

J&J's COVID-19 vaccine shows promise against Delta variantПодробнее

Johnson and Johnson vaccine shows promise in trialsПодробнее

Early trials show Johnson & Johnson vaccine is safe, effective against COVID-19Подробнее

Early Trials: Johnson & Johnson COVID Vaccine Prompts Immune ResponseПодробнее

Moderna’s COVID Vaccine Shows Promise in Early Trial: StudyПодробнее

Johnson & Johnson one dose vaccine sees immune response in early trialsПодробнее

Johnson & Johnson single-dose COVID-19 vaccine on trialПодробнее

Johnson & Johnson's single-shot vaccine proves effective in trial, but less so than Moderna, PfizerПодробнее

Johnson & Johnson in Phase 3 of one-dose vaccine trialПодробнее

COVID-19: Johnson & Johnson's single-shot vaccine 85% effective against most severe symptomsПодробнее

Johnson & Johnson COVID-19 vaccine offers protection with just 1 shot | GMAПодробнее

Johnson & Johnson Announces Single-Shot COVID-19 Vaccine | TODAYПодробнее

Johnson & Johnson 1-dose shot prevents COVID-19 in trial, but less than some othersПодробнее

Johnson & Johnson completes second phase trial of COVID-19 vaccine that requires one doseПодробнее

J&J reports positive phase 1/2 Covid-19 vaccine trial resultsПодробнее

Johnson & Johnson COVID-19 Vaccine Ships Out, Shows Promise Against Variant StrainsПодробнее

Johnson & Johnson releases results from phase three single-dose COVID-19 vaccine trialsПодробнее